United States: Monthly Stock Market Performance Insight - February 2025

Monthly Gainers
2,109
Monthly Losers
3,839
Average Return
-0.01%
Total Stocks
6,283
View Detailed Market Cap Breakdown
Market Cap Monthly Gainers Monthly Losers Average Return Total Stocks
Mega Cap 28 19 1.16% 47
Large Cap 342 380 -1.10% 724
Mid Cap 339 645 -4.26% 989
Small Cap 181 327 -4.51% 512

Monthly Streak Leaders for February 2025

Stock Streak Streak Return
9 months โ†‘ 291.34%

Palantir builds on success with a 9-month winning streak (21.70 โ†’ 84.92), delivering 291.3% gains. With 883.9M revenue generating only 217.7M profit (24.6% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

7 months โ†‘ 55.83%

Netflix maintains strong momentum with a 7-month winning streak (629.25 โ†’ 980.56), delivering 55.8% gains. The financials tell a compelling story: 10.5B revenue generating 2.9B net profit (27.4% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

5 months โ†“ -39.29%

Advanced Micro navigates difficult waters with a 5-month decline (164.48 โ†’ 99.86), down 39.3%. Weak margins on 7.4B revenue with only 709.0M profit (9.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

3 months โ†“ -5.83%

Microsoft pulls back after a 3-month decline (421.57 โ†’ 396.99), down 5.8%. However, fundamentals remain robust: 69.6B revenue generating 24.1B profit (34.6% margin) as of Qtr ending Dec 2024 suggests this could be a temporary setback. Value hunters take note.

12 months โ†‘ 97.12%

Fox continues its remarkable run with a 12-month winning streak (27.43 โ†’ 54.07), delivering 97.1% gains. With 4.4B revenue generating only 354.0M profit (8.1% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

8 months โ†‘ 53.98%

Primo Brands builds on success with a 8-month winning streak (21.88 โ†’ 33.69), delivering 54.0% gains. With 1.6B revenue generating only 28.7M profit (1.8% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

8 months โ†“ -39.29%

Biogen struggles to find footing after a 8-month decline (231.41 โ†’ 140.50), down 39.3%. Weak margins on 2.4B revenue with only 240.5M profit (9.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

6 months โ†“ -21.99%

Merck & Co sees continued selling pressure through a 6-month decline (118.26 โ†’ 92.25), down 22.0%. However, fundamentals remain robust: 15.5B revenue generating 5.1B profit (32.7% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

8 months โ†‘ 101.06%

Waystar Holding maintains strong momentum with a 8-month winning streak (21.62 โ†’ 43.47), delivering 101.1% gains. With 256.4M revenue generating only 29.3M profit (11.4% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

8 months โ†‘ 80.82%

Ptc Therapeutics maintains strong momentum with a 8-month winning streak (30.56 โ†’ 55.26), delivering 80.8% gains. The financials tell a compelling story: 1.2B revenue generating 866.6M net profit (73.7% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

8 months โ†“ -61.47%

Axcelis struggles to find footing after a 8-month decline (142.19 โ†’ 54.79), down 61.5%. However, fundamentals remain robust: 192.6M revenue generating 28.6M profit (14.8% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

7 months โ†“ -68.91%

Moderna sees continued selling pressure through a 7-month decline (99.58 โ†’ 30.96), down 68.9%. Financial struggles compound the decline: despite 107.0M revenue, - 971.0M losses persist (-907.5% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

10 months โ†‘ 153.35%

Coastal Financial continues its remarkable run with a 10-month winning streak (38.97 โ†’ 98.73), delivering 153.3% gains. With 105.0M revenue generating only 9.7M profit (9.3% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

9 months โ†‘ 89.41%

Everi Holdings maintains strong momentum with a 9-month winning streak (7.27 โ†’ 13.77), delivering 89.4% gains. With 181.3M revenue generating only 3.9M profit (2.2% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

9 months โ†“ -60.18%

Dorian LPG experiences extended pressure with a 9-month decline (51.13 โ†’ 20.36), down 60.2%. However, fundamentals remain robust: 75.9M revenue generating 8.1M profit (10.7% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

9 months โ†“ -39.21%

Blue Bird experiences extended pressure with a 9-month decline (57.81 โ†’ 35.14), down 39.2%. Revenue of 358.9M provides a foundation, but 26.0M net income (7.3% margin) in Qtr ending Mar 2025 highlights operational challenges that need addressing.

United States Market Monthly Gainers & Losers: February 2025

Top United States Stock Gainers (February 2025)

Stock Month Open Month Close Monthly Change Avg Daily Volume Month Volume
$128.91 $155.28 19.26% 6.2M 137.1M
$235.94 $269.69 15.76% 3.2M 70.7M
$23.69 $27.41 15.51% 34.5M 759.2M
$183.18 $209.03 13.67% 5.1M 111.9M
$804.27 $920.63 13.51% 3.1M 69.2M
$27.20 $41.46 45.37% 108.0M 2.4B
$14.88 $21.49 41.20% 11.3M 249.5M
$18.89 $27.11 33.94% 12.1M 266.6M
$22.17 $30.73 31.21% 7.0M 153.5M
$17.08 $22.27 27.77% 9.2M 202.6M
$36.93 $57.76 54.03% 3.2M 70.9M
$94.00 $135.17 38.64% 544.6K 12.0M
$70.37 $102.85 37.41% 1.4M 30.5M
$14.25 $19.95 35.81% 2.9M 63.9M
$25.18 $25.38 35.43% 3.0M 66.4M
$13.00 $12.36 375.38% 307.2K 6.8M
$4.30 $6.99 57.08% 2.9M 62.9M
$34.00 $52.72 42.18% 2.7M 59.5M
$8.92 $12.83 38.25% 3.9M 85.6M
$2.41 $3.40 37.10% 6.6M 145.5M

Biggest United States Stock Losers (February 2025)

Stock Month Open Month Close Monthly Change Avg Daily Volume Month Volume
$386.68 $292.98 -27.59% 71.9M 1.6B
$200.69 $170.28 -16.54% 28.6M 629.4M
$113.88 $99.86 -13.88% 36.3M 798.5M
$335.97 $297.85 -12.83% 6.4M 140.4M
$542.00 $474.96 -12.45% 4.7M 103.7M
$23.00 $24.00 -63.21% 3.5M 77.2M
$115.79 $70.32 -40.75% 10.4M 229.5M
$37.40 $24.57 -37.78% 13.7M 302.2M
$129.18 $88.74 -33.15% 3.1M 68.7M
$340.48 $232.34 -31.97% 1.3M 29.6M
$56.12 $32.29 -44.09% 1.4M 30.0M
$63.24 $38.19 -42.97% 3.2M 69.4M
$93.89 $55.20 -42.96% 4.0M 88.8M
$22.47 $13.97 -41.60% 1.8M 39.8M
$9.75 $6.07 -41.52% 12.4M 272.9M
$12.62 $5.72 -56.03% 8.1M 179.2M
$1.28 $0.67 -49.24% 776.3K 17.1M
$4.92 $2.98 -44.71% 351.2K 7.7M
$18.95 $11.40 -41.02% 2.8M 61.3M
$36.25 $22.14 -40.26% 1.6M 34.7M

Most Active United States Stocks During February 2025

Stock Month Open Month Close Monthly Change Avg Daily Volume Monthly Volume
$114.75 $124.92 4.04% 216.1M 4.8B
$27.20 $41.46 45.37% 108.0M 2.4B
$80.12 $84.92 2.95% 107.1M 2.4B
$18.97 $23.73 22.13% 105.0M 2.3B
$3.83 $5.16 21.70% 84.7M 1.9B
$2.66 $2.22 -19.57% 79.2M 1.7B
$9.72 $9.55 -5.26% 76.2M 1.7B
$14.10 $8.46 -35.76% 73.9M 1.6B
$386.68 $292.98 -27.59% 71.9M 1.6B
$5.63 $5.48 -7.74% 54.6M 1.2B
$4.17 $4.63 7.18% 52.4M 1.2B
$12.92 $10.75 -18.81% 49.6M 1.1B
$1.74 $1.49 -18.13% 48.2M 1.1B
$1.79 $1.61 -13.44% 48.1M 1.1B
$13.07 $10.82 -23.53% 44.5M 979.1M
$4.49 $4.85 5.90% 43.3M 952.2M
$4.29 $4.19 -12.16% 39.9M 877.6M
$229.99 $241.84 2.47% 39.2M 862.3M
$113.88 $99.86 -13.88% 36.3M 798.5M
$2.33 $2.26 -5.83% 27.1M 595.7M

United States Sector Performance During February 2025

Consumer Defensive

6.95%
245 stocks
Top Performers by Market Cap:
Mega Cap: PM +19.26%
Large Cap: HIMS +20.95%
Small Cap: UDMY +28.88%

Healthcare

5.57%
1230 stocks
Top Performers by Market Cap:
Mega Cap: ABBV +13.67%
Large Cap: RGC +21.05%
Small Cap: ESTA +33.76%

Technology

2.59%
818 stocks
Top Performers by Market Cap:
Mega Cap: CSCO +5.79%
Large Cap: SMCI +45.37%
Mid Cap: WRD +35.81%
Small Cap: PRCH +57.08%

Real Estate

0.93%
275 stocks
Top Performers by Market Cap:
Large Cap: BEKE +27.77%
Mid Cap: MPW +25.80%
Small Cap: SAFE +15.11%

Utilities

-0.12%
98 stocks
Top Performers by Market Cap:
Large Cap: DTE +11.53%
Mid Cap: UGI +11.16%
Small Cap: ARIS +23.23%

Financial Services

-0.98%
1078 stocks
Top Performers by Market Cap:
Mega Cap: BRK.A +10.30%
Large Cap: PGR +14.43%
Small Cap: BRDG +30.96%

Communication Services

-4.78%
265 stocks
Top Performers by Market Cap:
Mega Cap: TMUS +15.76%
Large Cap: TTWO +14.27%
Small Cap: LGF.A +27.01%

Basic Materials

-5.50%
266 stocks
Top Performers by Market Cap:
Mega Cap: LIN +4.69%
Large Cap: MT +12.26%
Small Cap: CSTM +14.60%

Consumer Cyclical

-6.07%
595 stocks
Top Performers by Market Cap:
Mega Cap: MCD +6.80%
Large Cap: XPEV +41.20%
Mid Cap: LNW +26.81%
Small Cap: MYTE +17.70%

Energy

-7.11%
217 stocks
Top Performers by Market Cap:
Mega Cap: CVX +6.32%
Large Cap: PSX +10.03%
Mid Cap: SOC +13.80%
Small Cap: SEI +25.14%

Industrials

-7.52%
699 stocks
Top Performers by Market Cap:
Mega Cap: GE +1.68%
Large Cap: RBA +14.42%
Mid Cap: TGI +35.43%
Small Cap: TIC +375.38%

Data is updated regularly. Monthly performance is calculated based on closing prices.